Literature DB >> 17027203

Changes in the ovarian dynamics and endocrine profiles in goats treated with a progesterone antagonist during the early luteal phase of the estrous cycle.

Chiho Suganuma1, Takenobu Kuroiwa, Tomomi Tanaka, Hideo Kamomae.   

Abstract

The aim of the present study was to determine the physiological role of endogenous progesterone in the regulation of ovarian dynamics, gonadotropin and progesterone secretion during the early luteal phase in the goat. Cycling Shiba goats received subcutaneously a vehicle (control group, n=5) or 50 mg of RU486 (RU486 group, n=4) daily from 1 to 7 days after ovulation (day 0) determined by transrectal ultrasonography. Ovarian dynamics were monitored by the ultrasonography and blood samples were collected daily until the subsequent ovulation for analysis of progesterone, luteinizing hormone (LH) and follicle stimulating hormone (FSH) secretion. Blood samples were also collected at 10 min intervals for 6 h on day 3 and day 7 for the analysis of pulsatile patterns of LH and FSH. The LH pulse frequency was significantly (P<0.05) higher in the RU486 group than in the control group on day 7 (4.8+/-1.1 pulses/6 h versus 1.2+/-0.4 pulses/6 h). The shape of the FSH pulses was unclear on day 3 and day 7 in both groups and the overall means of FSH concentration for 6 h on day 3 and day 7 were not significantly different between the RU486 and the control groups. The pattern of daily FSH concentrations showed a wave-like fluctuation in both groups. There was no significant difference in the inter-peak intervals of the wave-like pattern of daily FSH secretion between the RU486 and the control groups (4.1+/-0.6 days versus 4.5+/-0.6 days). The maximum diameter of the largest follicle that grew from day 1 to day 7 in the RU486 group tended to be greater than that in control goats (6.4+/-0.8 mm versus 5.0+/-0.8 mm, P=0.050), whereas no significant difference was detected in the size of the corpus luteum and progesterone concentrations between the control and RU486 groups on almost all days during the treatment period. These results indicate that the rise of the progesterone concentration suppresses the pulsatile LH secretion and follicular growth, whereas progesterone has no physiological role in the regulation of FSH secretion and luteal function during the early luteal phase of the estrous cycle in goats.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17027203     DOI: 10.1016/j.anireprosci.2006.09.015

Source DB:  PubMed          Journal:  Anim Reprod Sci        ISSN: 0378-4320            Impact factor:   2.145


  5 in total

1.  Estradiol and progesterone-induced slowing of gonadotropin-releasing hormone pulse frequency is not reversed by subsequent administration of mifepristone.

Authors:  Christopher R McCartney; Susan K Blank; John C Marshall
Journal:  Endocrine       Date:  2009-07-16       Impact factor: 3.633

2.  The efficacy of a newly developed neurokinin 3 receptor agonist B21-750 on luteinizing hormone secretion in cycling goats.

Authors:  Larasati Puji Rahayu; Natsumi Endo; Shinji Kuwai; Shinya Oishi; Tomomi Tanaka
Journal:  J Reprod Dev       Date:  2019-08-12       Impact factor: 2.214

3.  Changes in the ovary and the peripheral concentrations of sex hormones after the aspiration of follicular fluid from the spontaneous follicular cysts of dairy cows.

Authors:  Kazuhiro Kengaku; Tomomi Tanaka; Hideo Kamomae
Journal:  J Reprod Dev       Date:  2021-09-13       Impact factor: 2.214

4.  Exposure to estrogen mimicking the level of late pregnancy suppresses estrus subsequently induced by estrogen at the level of the follicular phase in ovariectomized shiba goats.

Authors:  Kiyosuke Nagai; Natsumi Endo; Tomomi Tanaka; Hideo Kamomae
Journal:  J Reprod Dev       Date:  2012-11-22       Impact factor: 2.214

5.  A population of kisspeptin/neurokinin B neurons in the arcuate nucleus may be the central target of the male effect phenomenon in goats.

Authors:  Kohei Sakamoto; Yoshihiro Wakabayashi; Takashi Yamamura; Tomomi Tanaka; Yukari Takeuchi; Yuji Mori; Hiroaki Okamura
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.